targeted cancer therapy companies
Companies whose enriched business profile is tagged “targeted cancer therapy”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + Finnhub, shown with its as-of date.
- Revolution Medicines (RVMD) Health Care — A precision oncology biotech in clinical development stages, pursuing targeted cancer therapies with no approved products yet but backed by substantial capital. ask →
- ERASCA INC (ERAS) Health Care — A precision oncology company developing first-in-class RAS/MAPK pathway-targeting therapies for cancers driven by the most frequently mutated oncogene affecting millions of patients annually. ask →
- TANGO THERAPEUTICS INC (TNGX) Health Care — A precision oncology company utilizing a proprietary functional genomics platform to discover and develop targeted, synthetic-lethal cancer therapies. ask →
- SYNDAX PHARMACEUTICALS INC (SNDX) Health Care — Syndax Pharmaceuticals is a clinical-stage and commercial-stage biotechnology company developing a pipeline of targeted cancer therapies, including approved treatments for leukemia and chronic graft-versus-host disease. ask →
- ORIC PHARMACEUTICALS INC (ORIC) Health Care — ORIC Pharmaceuticals is a clinical-stage oncology company developing targeted therapies for hard-to-treat cancers through precision medicine approaches. ask →
- KURA ONCOLOGY INC (KURA) Health Care — Clinical-stage oncology company commercializing KOMZIFTI for cancer and advancing a pipeline of targeted therapeutics through strategic partnerships. ask →
- AURA BIOSCIENCES INC (AURA) Health Care — Aura Biosciences is a clinical-stage biotech developing precision Viral-like Drug Conjugate (VDC) therapies designed to treat solid tumors while preserving organ function. ask →
- VERASTEM INC (VSTM) Health Care — A biopharmaceutical company developing targeted therapies for RAS/MAPK pathway-driven cancers, with a newly FDA-approved combination treatment for KRAS-mutated ovarian cancer and a pipeline focused on direct KRAS G12D inhibition. ask →
- WHITEHAWK THERAPEUTICS INC (WHWK) Health Care — Clinical-stage oncology company developing next-generation antibody-drug conjugates (ADCs) targeting validated tumor antigens with advanced linker-payload technology. ask →
- ADC THERAPEUTICS SA (ADCT) Health Care — ADC Therapeutics develops antibody-drug conjugates (ADCs) targeting hematologic and solid tumors, with its lead product ZYNLONTA commercialized for lymphoma. ask →
Not quite it? Describe exactly what you want →
Frequently asked
What are the largest targeted cancer therapy companies?
By market capitalization, the largest targeted cancer therapy companies in the catalog include Revolution Medicines (RVMD), ERASCA INC (ERAS), TANGO THERAPEUTICS INC (TNGX), SYNDAX PHARMACEUTICALS INC (SNDX), ORIC PHARMACEUTICALS INC (ORIC).
How many targeted cancer therapy companies does stocks-llm track?
stocks-llm currently lists 10 targeted cancer therapy companies (as of 2026-07-22), each with dated fundamentals from SEC EDGAR and Finnhub. Informational only — not financial advice.
Data: SEC EDGAR (filings) + Finnhub (fundamentals, delayed daily-close). Figures shown with their as-of date.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.